Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Collegium Pharmaceutical Inc (NASDAQ: COLL) closed at $26.37 up 3.78% from its previous closing price of $25.41. In other words, the price has increased by $3.78 from its previous closing price. On the day, 0.58 million shares were traded. COLL stock price reached its highest trading level at $26.8218 during the session, while it also had its lowest trading level at $24.34.
Ratios:
For a deeper understanding of Collegium Pharmaceutical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.17. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.95. In the meantime, Its Debt-to-Equity ratio is 4.28 whereas as Long-Term Debt/Eq ratio is at 3.99.
On July 30, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $47.
Jefferies Upgraded its Hold to Buy on June 07, 2024, whereas the target price for the stock was revised from $41 to $44.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 21 ’25 when Tupper Colleen sold 6,396 shares for $30.03 per share. The transaction valued at 192,069 led to the insider holds 156,667 shares of the business.
Tupper Colleen sold 1,206 shares of COLL for $36,181 on Mar 20 ’25. The EVP & Chief Financial Officer now owns 163,063 shares after completing the transaction at $30.00 per share. On Mar 21 ’25, another insider, Dreyer Scott, who serves as the EVP & Chief Commercial Officer of the company, sold 18,881 shares for $30.03 each. As a result, the insider received 566,983 and left with 103,613 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COLL now has a Market Capitalization of 847315584 and an Enterprise Value of 1703150592. As of this moment, Collegium’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.27, and their Forward P/E ratio for the next fiscal year is 3.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.34 while its Price-to-Book (P/B) ratio in mrq is 3.62. Its current Enterprise Value per Revenue stands at 2.697 whereas that against EBITDA is 4.618.
Stock Price History:
The Beta on a monthly basis for COLL is 0.69, which has changed by -0.2753504 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, COLL has reached a high of $42.29, while it has fallen to a 52-week low of $25.17. The 50-Day Moving Average of the stock is -11.13%, while the 200-Day Moving Average is calculated to be -19.96%.
Shares Statistics:
For the past three months, COLL has traded an average of 400.79K shares per day and 397770 over the past ten days. A total of 31.44M shares are outstanding, with a floating share count of 30.91M. Insiders hold about 3.81% of the company’s shares, while institutions hold 117.40% stake in the company. Shares short for COLL as of 1741910400 were 5267787 with a Short Ratio of 13.14, compared to 1739491200 on 5206789. Therefore, it implies a Short% of Shares Outstanding of 5267787 and a Short% of Float of 20.86.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
